Novo Nordisk A/S ADR buy Argus
Start price
10.06.24
/
50%
€132.00
Target price
10.06.25
€148.83
Performance (%)
-47.35%
End price
11.06.25
€69.50
Summary
This prediction ended on 11.06.25 with a price of €69.50. Massive losses of -47.35% were the result for the BUY prediction by Argus. A total of €1.56 was paid as dividends for this prediction. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 5.906% | 5.906% | -35.800% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by Argus for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at Argus from $125.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Argus gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Argus for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.60
02.10.23
02.10.23
€104.76
02.10.24
02.10.24
22.66%
03.10.24
03.10.24
